Special Issue "Diagnosis and Treatment of Pneumonia"
Deadline for manuscript submissions: closed (31 December 2019) | Viewed by 80507
Interests: respiratory medicine; epidemiology; risk factors; outcome; treatment; prevention and pathogenetic mechanisms of respiratory infections; community-acquired pneumonia; intensive care
Special Issues, Collections and Topics in MDPI journals
Special Issue in Medical Sciences: COPD Exacerbations
Special Issue in Medical Sciences: Idiopathic Pulmonary Fibrosis
Special Issue in Medical Sciences: Feature Papers in Medical Sciences
Special Issue in Biomedicines: Pneumonia Basic Science
Special Issue in Medical Sciences: Pneumonia Basic Science
Special Issue in Medical Sciences: 10th Anniversary of Medical Sciences — Advances in Basic, Translational and Clinical Research
Pneumonia is a severe health problem and a significant cause of mortality and morbidity worldwide. The burden of pneumonia is expected to grow given the increasing aging population, the number of patients with multiple comorbidities, including immunosuppression, and the emergence of antibiotic resistance pathogens. PES pathogens (Pseudomonas aeruginosa, extended-spectrum β-lactamase Enterobacteriaceae, and methicillin-resistant Staphylococcus aureus) account for approximately 6% of cases of community-acquired pneumonia (CAP) with microbiological diagnosis. Multidrug-resistant (MDR) pathogens account for approximately half of the microbiologically confirmed cases of ventilator-associated pneumonia (VAP).
Despite improvements in its management, due to the implementation of international guidelines for community-acquired, hospital-acquired, and ventilator-associated pneumonia, the diagnosis of pneumonia is still a challenge, especially in specific populations, such as elderly patients and immunocompromised patients. Our current clinical practice is insufficient to reduce the associated morbidity and mortality rates, as well as to avoid short- and long-term sequelae. There is a need for novel approaches to be incorporated in the clinical practice, embracing new knowledge, prevention measures, and therapeutic strategies.
Prof. Dr. Antoni Torres
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- community-acquired pneumonia
- hospital-acquired pneumonia
- ventilator-associated pneumonia
- respiratory infections